Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer

BMC Medical Informatics and Decision Making - Tập 12 - Trang 1-5 - 2012
Charlotte J Verberne1, Cornelis H Nijboer1, Geertruida H de Bock2, Irene Grossmann3, Theo Wiggers1, Klaas Havenga1
1Department of Surgery, University Medical Center Groningen, RB Groningen, The Netherlands
2Department of Epidemiology, University Medical Center Groningen, RB Groningen, The Netherlands
3Department of Surgery, Catharina Hospital, ZA Eindhoven, The Netherlands

Tóm tắt

The present paper is a first evaluation of the use of "CEAwatch", a clinical support software system for surgeons for the follow-up of colorectal cancer (CRC) patients. This system gathers Carcino-Embryonic Antigen (CEA) values and automatically returns a recommendation based on the latest values. Consecutive patients receiving follow-up care for CRC fulfilling our in- and exclusion criteria were identified to participate in this study. From August 2008, when the software was introduced, patients were asked to undergo the software-supported follow-up. Safety of the follow-up, experiences of working with the software, and technical issues were analyzed. 245 patients were identified. The software-supported group contained 184 patients; the control group contained 61 patients. The software was safe in finding the same amount of recurrent disease with fewer outpatient visits, and revealed few technical problems. Clinicians experienced a decrease in follow-up workload of up to 50% with high adherence to the follow-up scheme. CEAwatch is an efficient software tool helping clinicians working with large numbers of follow-up patients. The number of outpatient visits can safely be reduced, thus significantly decreasing workload for clinicians.

Tài liệu tham khảo

Edelman MJ, Meyers FJ, Siegel D: The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. Journal of General Internal Medicine. 1997, 12 (5): 318-331. Grossmann I, de Bock GH, van de Velde CJH, Kievit J, Wiggers T: Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up. Colorectal Disease. 2007, 9: 787-792. 10.1111/j.1463-1318.2007.01303.x. Reinauer H, Graham Wood W: External quality assessment of tumour marker analysis: State of the art and consequences for estimating diagnostic sensitivity and specificity. Ger Med Sci. 2005, 3: Doc02 Staab HJ, Anderer FA, Stumpf E, Fischer R: Slope analysis of the post-operative CEA time course and its possible application as an aid in diagnosis of disease progression in gastro-intestinal cancer. Am J Surg. 1978, 136: 322-327. 10.1016/0002-9610(78)90285-4. Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R: Follow-up of colorectal cancer pa tients after resection withcurative intent - the GILDA trial. Surg Oncol. 2004, 13: 119-124. 10.1016/j.suronc.2004.08.005. Goud R, van Engen-Verheul M, de Keizer NF, Bal R, Hasman A, Hellemans IM, Peek N: The effect of computerized decision support on barriers to guideline implementation: A qualitative study in outpatient cardiac rehabilitation. Int J Med Inform. 2010, 79 (6): 430-437. 10.1016/j.ijmedinf.2010.03.001. O'Brien MA, Rogers S, Jamtvedt S: Educational outreach visits: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007, 4: CD000409 Kawamoto K, Houlihan CA, Balas EA, Lobach DF: Improving clinical practice using clinical decision support systems: A systematic review of trials to identify features critical to success. BMJ. 2005, 330 (7494): 765-10.1136/bmj.38398.500764.8F. Morris AH: Developing and implementing computerized protocols for standardization of clinical decisions. Ann Intern Med. 2000, 132 (5): 373-383. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6947/12/14/prepub